Test Price
2,800 AED✅ Home Collection Available
TUBB4A Gene Leukodystrophy Hypomyelinating Type 6 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TUBB4A لاعتلال بيضاء الدماغ ناقص الميالين من النوع 6 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🔬 Diagnostic Confidence, Delivered with UAE-Compliant Precision
- 99.9% Diagnostic Sensitivity via ISO 15189:2022 accredited NGS workflow and dual independent variant interpretation.
- Hospital-Grade Home Collection —8 AM to 11 PM VIP mobile phlebotomy with ISO-certified cold-chain transport to our DHA-licensed molecular facility.
- Post-Test Clinical Guidance —Telephonic result interpretation with a DHA-registered neurologist or genetic counsellor, included for all patients.
- Direct Insurance Billing Verification —WhatsApp your Emirates ID & policy number to +971 54 548 8731 for instant pre-approval check.
دقة تشخيصية لا مثيل لها 99.9% عبر تقنية التسلسل الجيني المتقدم، مع خدمة سحب منزلي طبي معتمدة واستشارة متابعة بعد الفحص. فحص جيني أساسي لتأكيد اعتلال بيضاء الدماغ ناقص الميالين النوع السادس والتخطيط العائلي للمستقبل.
Test Overview
The TUBB4A NGS test detects pathogenic variants in the TUBB4A gene that cause hypomyelinating leukodystrophy type 6—a rare, progressive white-matter disorder typically presenting in infancy or early childhood with motor delay, ataxia, and spasticity. This single-gene sequencing assay provides definitive molecular confirmation, enabling early therapeutic intervention, precise genetic counseling, and cascade family screening.
| Feature | Our TUBB4A NGS Test | Closest Alternative (Research-Use Panel) |
|---|---|---|
| Precision | 99.9% base-calling accuracy with 30X mean coverage across all coding exons ±10 bp splice sites | Variable; often ≤95% coverage for GC-rich exon 1 |
| Methodology | CLIA-validated NGS with orthogonal Sanger confirmation of all pathogenic/likely pathogenic calls | Research-grade NGS, no clinical confirmation step |
| Turnaround Time | 3–4 Weeks (expedited 10-day option available) | 6–8 Weeks |
| Clinical Report | DHA-compliant report with ACMG-based variant classification, clinical correlation, and genetic counseling recommendations | Basic variant list without clinical interpretation |
Physician Insight & Safety Protocol
“While a positive TUBB4A result confirms the molecular diagnosis, clinical correlation remains essential—mild mutations may present with minimal symptoms into adulthood, whereas severe variants cause devastating early-onset disease. I counsel families that this test provides clarity for treatment planning, developmental support, and informed reproductive choices, but it must be interpreted in the context of MRI findings and neurological examination.”
— Dr. Prabhakar Reddy, DHA License No. 61713011, Consultant Neurologist.
⚠️ Medication Warning
Do not discontinue any prescribed antiepileptic, antispastic, or supportive medication without consulting your treating neurologist. Abrupt changes can precipitate seizures or worsening of spasticity.
🚨 Exclusion Criteria & Emergency Red Flags
- Active febrile illness or acute neurological decompensation within 48 hours—reschedule collection.
- Inability to provide minimum blood volume (0.5 mL for paediatric patients) despite optimized phlebotomy.
- Red Flags requiring immediate ER visit before proceeding: acute onset of coma, status epilepticus, or suspicion of acute brain stem compression.
Patient FAQ & Clinical Guidance
1. What does this TUBB4A test actually tell me about my child's condition?
This NGS identifies disease-causing mutations in the TUBB4A gene to confirm a molecular diagnosis of hypomyelinating leukodystrophy type 6 and guide prognosis and family planning. It distinguishes it from other white-matter disorders like Pelizaeus-Merzbacher disease. A positive result ends the diagnostic odyssey and allows your clinical team to tailor supportive therapies, while a negative result may prompt broader genetic testing.
2. Why is home collection available and is it safe for a child with neurological symptoms?
Our DHA-certified paediatric phlebotomists use a one-drop FTA card or small-volume blood draw specially designed for fragile infants and children with spasticity or movement disorders. The cold-chain transport preserves DNA integrity until it reaches our ISO-lab, where extraction occurs within 2 hours. Parents may accompany the child throughout, and we provide distraction techniques to minimize discomfort.
3. هل هذا الفحص مؤلم للأطفال وكيف يمكن تحضير الطفل؟
لا، الفحص سريع وغير مؤلم لأنه يستخدم بطاقة FTA التي تحتاج قطرة دم واحدة فقط أو سحب كمية قليلة جداً من الوريد. ينصح بإعطاء الطفل سوائل كافية قبل الفحص ويمكن استخدام كريم تخدير موضعي بوصفة الطبيب. فريقنا المتنقل مدرب على سحب عينات الأطفال المصابين بحالات عصبية بطريقة آمنة ولطيفة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians